AgomAb Therapeutics NV (NASDAQ:AGMB) IPO
IPO
Priced at US$16.00 an ADS on Feb 5, 2026.
- Price
- US$16.00 an ADS
- Offering size
- US$200 million
- Underwriters' option
- Up to 1,875,000 more ADSs
- Listing
- AGMB on the Nasdaq Global Select Market
- Underwriters
- J.P. Morgan, Morgan Stanley, Leerink Partners, Van Lanschot Kempen · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jun 20, 2024 |
| Filed publicly | Jan 16, 2026 |
| Amended once | Jan 29, 2026 |
| Declared effective by the SEC | Jan 30, 2026 |
| Shares registered with an exchange | Feb 3, 2026 |
| Final prospectus, with the price | Feb 6, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Feb 6, 2026 |
| CERT · Exchange's certificate of listing | Feb 5, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Feb 3, 2026 |
| EFFECT · Notice that a registration is effective | Jan 30, 2026 |
| F-1/A · Registration statement, amended | Jan 29, 2026 |
| F-1 · Registration statement | Jan 16, 2026 |
| DRS/A · Draft registration statement, amended | Dec 17, 2025 |
| DRS/A · Draft registration statement, amended | Oct 28, 2025 |
| DRS · Draft registration statement | Jun 20, 2024 |
From the cover of the final prospectus (424B4) filed Feb 6, 2026